Physician profile
Robert Henry Packer
NPI 1366453516
$1,086.04
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $549 · 2020: $276 · 2021: $261.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $259.77 | 2019-2021 | |
| Janssen Biotech, INC. | $150.68 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $132.07 | 2019-2021 | |
| Lilly USA, LLC | $131.12 | 2019-2021 | |
| Dusa Pharmaceuticals, INC. | $59.37 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $58.65 | 2019-2020 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $56.69 | 2019-2020 | |
| Genzyme Corporation | $49.85 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $36.19 | 2020-2021 | |
| Leo Pharma INC. | $26.63 | 2021 | |
| Amgen INC. | $23.88 | 2019 | |
| Dermira, INC. | $23.00 | 2020 | |
| Biofrontera INC. | $18.13 | 2019 | |
| Aclaris Therapeutics, INC. | $17.24 | 2019 | |
| Galderma Laboratories, L.P. | $15.61 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $14.96 | 2019 | |
| Mayne Pharma Commercial LLC | $12.20 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Packer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.